Clinical Trial Update: A Study of MK0663 and an Approved Drug in the Treatment of Osteoarthritis (0663-077)(COMPLETED) [Phase 3]

View source ↗

Summary

This document reports the completion of a Phase 3 trial evaluating MK0663 in combination with an approved drug for osteoarthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• Approved Drug (undisclosed)
• MK0663

Snippet

Sponsor: Organon and Co | Conditions: Osteoarthritis | Phase 3 | Status: COMPLETED